Azilsartan National NME Drug Monograph

iii. ACE-Inhibitors (ACE-I) or angiotensin receptor blockers (ARBs) if patient is 6 months or more from transplant (ex: lisinopril, losartan) 1. Potential cardioprotection and renal protection. May be drug of choice in some patients with diabetes mellitus and/or cardiovascular disease or low EF. 2.Avoid if K > 5.53. Avoid if SCr > 3 mg/dL4. ................
................